Posted on: October 29, 2014
First and only FDA-approved drug coated balloon is now available for
Atlanta, Georgia – Northside Hospital Healthcare System is the first in Georgia to offer a new state-of-the-art treatment for peripheral arterial disease (PAD), a disease that creates blockages caused by plaque build-up in arteries that carry blood to the head, organs and limbs.
The LUTONIX® 035 Drug Coated Balloon PTA Catheter (DCB) is the first and only treatment of its kind approved by the U.S. Food and Drug Administration (FDA). Dr. Joseph Ricotta performed Georgia’s first DCB procedure on October 15, 2014 at Northside Hospital-Forsyth in Cumming.
Dr. Ricotta is the chair of vascular surgery and endovascular therapy and the medical director of vascular services of the Northside Hospital Heart & Vascular Institute.
“We are committed to bringing cutting-edge technology and innovations in care to our patients, and it is exciting to be the first hospital in Georgia to offer this new treatment,” said Dr. Ricotta, “The Lutonix DCB is an advanced first-line therapy for treating blockages without completely ruling out other treatment options in the future, which is a key consideration when offering patients the best treatment possible.”
PAD in the femoropopliteal artery, a potentially life-threatening condition, affects millions of Americans by narrowing arteries and reducing blood flow to the limbs, according to American Heart Association (AHA) estimates. Patients with PAD in the femoropopliteal arteries are at risk for lower-extremity amputation, particularly in people over the age of 50. Minimally-invasive endovascular procedures such as angioplasty balloons, stents, medications and vascular bypass surgery are some of the accepted ways to treat PAD, but these options may be limited depending on the type of arterial blockage.Successful treatment of PAD leads to improved blood flow (patency) for longer periods of time. The LUTONIX® 035 DCB uniquely combines an angioplasty balloon coated with a low dose of Paclitaxel to improve blood flow in blocked vessels in the legs.
Filed under: Latest News & Technology,